NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
April 25, 2025 — Nutriband introduces AVERSA(TM) technology to enhance drug safety and accessibility. Learn about the company's innovative approach to pharmaceutical development and its potential impact on the industry. Stay informed about Nutriband's latest advancements in the field.
April 25, 2025 — D-Wave and Japan Tobacco partner on a quantum computing project to revolutionize drug discovery. Through the use of AI and quantum technology, they aim to enhance pharmaceutical design and accelerate treatments. Learn more about the impact of this innovative collaboration.
April 25, 2025 — Adageis introduces AI-powered financial technology platform for healthcare providers to transition to value-based care. Predicting revenue performance and optimizing financial efficiency, Adageis' solutions revolutionize healthcare operations.
April 25, 2025 — New study reveals link between bacteria and multiple sclerosis risk, offering potential treatment insights. Clene Inc. and BioMedWire play key roles in advancing research and communication in biotechnology and life sciences.
April 25, 2025 — Calidi Biotherapeutics announces an inducement grant to new CEO Dr. Eric Poma, highlighting the company's innovative approach to developing targeted antitumor virotherapies. The grant signifies confidence in leadership and potential for revolutionary cancer treatment.
April 25, 2025 — Soligenix (NASDAQ: SNGX), a biopharmaceutical company, reveals promising results for its lead candidate, HyBryte, in treating rare skin cancer. With a 75% response rate in clinical trials, HyBryte shows potential as a groundbreaking therapy for cutaneous T-cell lymphoma.
April 25, 2025 — Creative Biolabs leads in CIK cell therapy development for cancer treatment, offering one-stop solutions from concept to clinic. Learn how their innovative approach advances cancer immunotherapy research.
April 25, 2025 — Cancer Support Community SF Bay Area breaks ground on new cancer support center in Lafayette, CA as part of 'Rooted in Resilience' Capital Campaign. Key figures like Mayor of Lafayette and Congressman Mark DeSaulnier attend event to show support for comprehensive cancer care programs.
April 24, 2025 — GeoVax Labs responds to the detection of Clade I Mpox viral particles in North Carolina, emphasizing the need for expanded preparedness and vaccine availability. Learn how the company's GEO-MVA vaccine is advancing as a key U.S.-developed candidate for Mpox/smallpox.
April 24, 2025 — Utah Healthcare Innovation Network partners with local organizations to accelerate healthcare startups and drive innovation in the industry. Learn how this initiative is set to improve healthcare accessibility, affordability, and quality in Utah.
April 24, 2025 — Helix BioPharma Corp. announces the appointment of Veronika Kandziora as COO and Jessica Kourniaktis as Director of Communications to drive growth and advance the fight against hard-to-treat cancers. Learn more about the strategic moves and key players at Helix.
April 24, 2025 — InnerScope (OTC: INND) officially opens OTCHealthMart.com, a platform offering a variety of OTC health products. CEO Matthew Moore expresses commitment to affordable healthcare solutions and plans to expand offerings to include durable medical equipment.
April 24, 2025 — InnerScope launches OTCHealthMart.com, a platform offering OTC health and wellness products. The move aims to improve healthcare accessibility and affordability for consumers, including the 55+ demographic.
April 24, 2025 — NAVEX introduces NAVEX One, a platform offering centralized policy management, employee training, and risk assessment solutions aligned with HIPAA for healthcare organizations. Learn how NAVEX is streamlining HIPAA compliance, reducing administrative burden, and supporting a proactive approach to privacy and risk management.
April 24, 2025 — Discover how NAVEX One is transforming HIPAA compliance for healthcare organizations with centralized policy management, employee training, and risk assessment solutions. Learn how this platform streamlines compliance efforts, enhances privacy and security programs, and helps organizations meet regulatory requirements.
April 24, 2025 — GeoVax Labs presents successful clinical data on GEO-CM04S1 vaccine at World Vaccine Congress, highlighting robust immune responses in healthy and immunocompromised populations. The dual-antigen approach demonstrates durable T cell and antibody responses, positioning the vaccine as a promising solution for COVID-19 protection.
April 24, 2025 — NeuroSense Therapeutics is on the verge of a groundbreaking pharmaceutical partnership for its ALS therapy, PrimeC, showcasing a 58% survival improvement. The nearing deal could fully fund the upcoming Phase 3 trial, marking a significant milestone for the company in the neurodegenerative disease market.
April 24, 2025 — NeuroSense Therapeutics is on the verge of a potential blockbuster pharma deal as their ALS drug shows a 58% survival improvement. Stay tuned for updates on this transformative partnership and the promising PrimeC therapy.
April 24, 2025 — Soligenix announces positive results for HyBryte™ skin cancer treatment, with 75% of patients showing improvement in CTCL after 18 weeks. The treatment offers a faster and safer alternative, potentially revolutionizing the standard of care for this rare disease.
April 24, 2025 — Discover how stem cell therapy is transforming the landscape of blood cancer treatment and providing hope for leukemia, myeloma, and lymphoma patients. Learn more about the innovative work of Calidi Biotherapeutics Inc. in advancing this life-saving treatment.